President Trump published letters to 17 major pharma companies reiterating his requirements for them to fulfill his MFN order ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

White House Press Secretary Karoline Leavitt announced at Thursday's press conference that President Donald Trump had signed ...

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

President Donald Trump sent a letter to 17 drug companies demanding a commitment to bring down prices in the next 60 days through a series of initiatives.

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President ...

The FDA greenlit multiple new drugs this month and issued some notable label expansions including for Eli Lilly’s Kisunla.